D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$708M |
| 2 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$614M |
| 3 |
Merck
MRK
|
+$521M |
| 4 |
Bank of America
BAC
|
+$492M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$285M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$646M |
| 2 |
Tesla
TSLA
|
+$607M |
| 3 |
Microsoft
MSFT
|
+$491M |
| 4 |
Accenture
ACN
|
+$482M |
| 5 |
Broadcom
AVGO
|
+$438M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.84% |
| 2 | Consumer Discretionary | 9.28% |
| 3 | Healthcare | 6.84% |
| 4 | Financials | 6.63% |
| 5 | Industrials | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3426
Inspire Medical Systems
INSP
$1.5B
| $627K | ﹤0.01% |
2,973
-20,310
| -87% | -$3.53M |
|
3427
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.09B
| $626K | ﹤0.01% |
13,701
+1,046
| +8% | +$45.2K |
|
3428
Traeger
COOK
$164M
| $626K | ﹤0.01% |
3,403
+929
| +38% | +$138K |
|
3429
PUT
Xerox
XRX
$360M
| $625K | ﹤0.01% |
+60,200
| New | +$644K |
|
3430
Independent Bank Corp
IBCP
$797M
| $624K | ﹤0.01% |
18,700
-3,849
| -17% | -$123K |
|
3431
iShares MSCI Turkey ETF
TUR
$204M
| $623K | ﹤0.01% |
17,138
-34,725
| -67% | -$1.37M |
|
3432
Cytokinetics
CYTK
$10.8B
| $623K | ﹤0.01% |
+11,790
| New | +$657K |
|
3433
CNO Financial Group
CNO
$5B
| $622K | ﹤0.01% |
17,729
-110,964
| -86% | -$3.57M |
|
3434
Aspen Aerogels
ASPN
$364M
| $622K | ﹤0.01% |
22,465
-519,040
| -96% | -$13M |
|
|
TIXT
3435
DELISTED
TELUS International
TIXT
| $620K | ﹤0.01% |
+158,883
| New | +$715K |
|
3436
Old Republic International
ORI
$10.8B
| $620K | ﹤0.01% |
17,491
-29,078
| -62% | -$984K |
|
3437
CALL
ZTO Express
ZTO
$18.2B
| $619K | ﹤0.01% |
25,000
| – | – |
|
3438
NRC Health Common Stock
NRC
$503M
| $619K | ﹤0.01% |
27,083
-9,282
| -26% | -$210K |
|
3439
Sasol
SSL
$7.03B
| $614K | ﹤0.01% |
90,770
-167,053
| -65% | -$1.24M |
|
3440
iShares S&P Small-Cap 600 Value ETF
IJS
$8.2B
| $613K | ﹤0.01% |
5,691
-66,847
| -92% | -$6.94M |
|
3441
Invesco S&P MidCap 400 Pure Value ETF
RFV
$336M
| $608K | ﹤0.01% |
5,133
| – | – |
|
3442
CALL
AMN Healthcare
AMN
$1.35B
| $606K | ﹤0.01% |
14,300
-25,700
| -64% | -$1.35M |
|
3443
Madison Square Garden
MSGE
$3.65B
| $602K | ﹤0.01% |
+14,166
| New | +$553K |
|
3444
Vanguard Extended Market ETF
VXF
$30.5B
| $601K | ﹤0.01% |
3,303
-38,472
| -92% | -$6.73M |
|
3445
EastGroup Properties
EGP
$11.3B
| $600K | ﹤0.01% |
+3,213
| New | +$592K |
|
3446
PUT
Ginkgo Bioworks
DNA
$503M
| $598K | ﹤0.01% |
+73,400
| New | +$735K |
|
3447
PUT
Methode Electronics
MEI
$525M
| $598K | ﹤0.01% |
50,000
-9,900
| -17% | -$111K |
|
3448
American Financial Group
AFG
$12B
| $598K | ﹤0.01% |
4,442
+490
| +12% | +$63.5K |
|
|
NPKI
3449
NPK International
NPKI
$1.09B
| $597K | ﹤0.01% |
86,138
-74,603
| -46% | -$574K |
|
|
BLDP
3450
Ballard Power Systems
BLDP
$808M
| $597K | ﹤0.01% |
331,609
-163,746
| -33% | -$328K |
|
Similar funds
D.E. Shaw & Co's Q3 2024 Portfolio in Review
As of Q3 2024, D.E. Shaw & Co held 5,052 positions worth $116B, up 8.9% from $107B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2024 filing shows 599 new, 1,568 increased, 1,742 reduced and 558 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M. The largest sale was Adobe, an estimated $646M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q3 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,429,800 shares worth $115M.
- D.E. Shaw & Co added most to NVIDIA in Q3 2024, an estimated $708M increase.
- D.E. Shaw & Co's biggest Q3 2024 reduction was Adobe, cutting an estimated $646M.
- D.E. Shaw & Co fully exited WestRock Company in Q3 2024, selling an estimated $148M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $116B portfolio in Q3 2024.
- D.E. Shaw & Co opened 599 new positions and closed 558 in Q3 2024.
- D.E. Shaw & Co's portfolio value rose 8.9% quarter-over-quarter to $116B.
Based on D.E. Shaw & Co's 13F filing for Q3 2024, filed 14 Nov 2024.